FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products approved in 2021 by the FDA. Approval of biosimilar products can increase patient access to safe and effective treatment options.
News Medical on MSN9d
How olive oil bioactives regulate genes linked to insulin resistanceOlive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...
Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
A new systematic review and meta-analysis published in the Clinical Nutrition ESPEN revealed promising outcomes for the ...
News Medical on MSN12d
Improving insulin sensitivity with regular mango consumptionA recently study published in Nutrients reports that the regular consumption of mangoes may improve inflammation, insulin ...
Study results indicated that controlling diabetes with insulin helps to prevent the emergence of antibiotic-resistant S. aureus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback